Article
Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.
Drug metabolism reviews - 1 May 2004
Yu Ai-Ming, Idle Jeffrey R, Gonzalez Frank J
Abstract excerpt
Cytochrome P450 2D6 (CYP2D6) is the first well-characterized polymorphic phase I drug-metabolizing enzyme, and more than 80 allelic variants have been identified for the CYP2D6 gene, located on human chromosome 22q13.1. Human debrisoquine and sparteine metabolism is subdivided into two principal phenotypes--extensive metabolizer and poor metabolizer--that arise from variant CYP2D6 genotypes. It has been estimated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
